Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Debt Ratio: 2022-2025

Historic Debt Ratio for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to 0.24.

  • Centessa Pharmaceuticals' Debt Ratio rose 97.30% to 0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24, marking a year-over-year increase of 97.30%. This contributed to the annual value of 0.19 for FY2024, which is 10.12% down from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Debt Ratio is 0.24, which was up 10.05% from 0.22 recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Debt Ratio peaked at 0.24 during Q3 2025, and registered a low of 0.12 during Q3 2024.
  • Its 3-year average for Debt Ratio is 0.20, with a median of 0.20 in 2023.
  • Its Debt Ratio has fluctuated over the past 5 years, first crashed by 36.69% in 2024, then surged by 97.30% in 2025.
  • Quarterly analysis of 4 years shows Centessa Pharmaceuticals' Debt Ratio stood at 0.16 in 2022, then surged by 33.76% to 0.21 in 2023, then decreased by 10.12% to 0.19 in 2024, then soared by 97.30% to 0.24 in 2025.
  • Its Debt Ratio stands at 0.24 for Q3 2025, versus 0.22 for Q2 2025 and 0.21 for Q1 2025.